IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The company's President and CEO, Jay Mazelsky, along with Executive VP and CFO, Brian McKeon, will engage in a fireside chat on Wednesday, September 4, 2024, from 11:30 am to 12:05 pm (EDT).
Investors and interested parties can access a live audio webcast of the presentation through the IDEXX website at www.idexx.com/investors. For those unable to attend the live event, an archived version of the presentation will also be made available through the same link.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), un leader globale nell'innovazione nel settore della salute degli animali domestici, ha annunciato la sua partecipazione alla 22ª Conferenza Annuale Globale sulla Salute di Morgan Stanley. Il Presidente e CEO dell'azienda, Jay Mazelsky, insieme al VP Esecutivo e CFO, Brian McKeon, parteciperanno a un fireside chat mercoledì 4 settembre 2024, dalle 11:30 alle 12:05 (EDT).
Investitori e parti interessate possono accedere a un webcast audio in diretta della presentazione attraverso il sito web di IDEXX all'indirizzo www.idexx.com/investors. Per coloro che non possono partecipare all'evento live, sarà disponibile anche una versione archiviata della presentazione attraverso lo stesso link.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), un líder global en innovación en salud animal, ha anunciado su participación en la 22ª Conferencia Anual Global de Salud de Morgan Stanley. El presidente y CEO de la empresa, Jay Mazelsky, junto con el VP Ejecutivo y CFO, Brian McKeon, participarán en una charla informal el miércoles 4 de septiembre de 2024, de 11:30 a.m. a 12:05 p.m. (EDT).
Los inversores y las partes interesadas pueden acceder a un webcast de audio en vivo de la presentación a través del sitio web de IDEXX en www.idexx.com/investors. Para aquellos que no puedan asistir al evento en vivo, también estará disponible una versión archivada de la presentación a través del mismo enlace.
IDEXX Laboratories, Inc. (NASDAQ: IDXX)는 애완동물 헬스케어 혁신의 글로벌 리더로서 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스에 참가할 것이라고 발표했습니다. 회사의 대통령이자 CEO인 Jay Mazelsky와 수석 부사장 겸 CFO인 Brian McKeon이 2024년 9월 4일 수요일, 오후 11:30부터 오후 12:05(EDT)까지 파이어사이드 챗에 참여할 예정입니다.
투자자 및 관련자들은 www.idexx.com/investors 웹사이트를 통해 발표의 실시간 오디오 웹캐스트에 접근할 수 있습니다. 실시간 이벤트에 참석할 수 없는 분들을 위해 동일한 링크를 통해 아카이브된 버전도 제공될 예정입니다.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), un leader mondial de l'innovation en santé animale, a annoncé sa participation à la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. Le Président et CEO de l'entreprise, Jay Mazelsky, ainsi que le VP Exécutif et CFO, Brian McKeon, participeront à une discussion informelle le mercredi 4 septembre 2024, de 11h30 à 12h05 (EDT).
Les investisseurs et les parties intéressées peuvent accéder à un webinaire audio en direct de la présentation via le site web d'IDEXX à www.idexx.com/investors. Pour ceux qui ne peuvent pas assister à l'événement en direct, une version archivée de la présentation sera également disponible via le même lien.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), ein globaler Marktführer in der Innovation der Tiergesundheitsversorgung, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley bekannt gegeben. Der Präsident und CEO des Unternehmens, Jay Mazelsky, sowie der Executive VP und CFO, Brian McKeon, werden am Mittwoch, den 4. September 2024, von 11:30 bis 12:05 Uhr (EDT) an einem Fireside Chat teilnehmen.
Investoren und Interessierte können über die IDEXX-Website www.idexx.com/investors auf ein Live-Audio-Webcast der Präsentation zugreifen. Für diejenigen, die nicht an der Live-Veranstaltung teilnehmen können, wird über denselben Link auch eine archivierte Version der Präsentation zur Verfügung stehen.
- None.
- None.
A live audio webcast of the presentation will be available through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the presentation will be available via the same link.
About IDEXX Laboratories, Inc.
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240821703657/en/
Investor Relations
investorrelations@idexx.com
Source: IDEXX Laboratories, Inc.
FAQ
When is IDEXX Laboratories (IDXX) presenting at the Morgan Stanley Healthcare Conference?
Who will represent IDEXX Laboratories (IDXX) at the Morgan Stanley Healthcare Conference?
How can investors access IDEXX Laboratories' (IDXX) presentation at the Morgan Stanley conference?